Mercer Global Advisors Inc Novavax Inc Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Novavax Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 13,742 shares of NVAX stock, worth $104,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,742Holding current value
$104,301% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding NVAX
# of Institutions
307Shares Held
94.9MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.2MShares$115 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$89.9 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$87.4 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$51.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$29.9 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $594M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...